Back

1-year MILOS insights: real-world evidence confirming combination

30 August 2026 (10:21 - 10:29)
Organised by: Logo
Congress Presentation Part of: From guidelines to real-world practice: advancing low-density lipoprotein cholesterol control Lipid-Lowering Agents Open Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Associate Professor Thomas M Stulnig

Clinic Hietzing, Vienna (Austria)

5 More presentations in this session

Presentation thumbnail
Welcome and introduction 
Professor A. Catapano (Milan, IT)
Presentation thumbnail
New guidelines: key changes with clinical impact
Professor F. Mach (Geneva, CH)
Presentation thumbnail
Preventing cardiovascular events through oral triple combination therapy
Professor K. Stach-Jablonski (Potsdam, DE)
Presentation thumbnail
Panel discussion and audience "Q&A"
Presentation thumbnail
Closing remarks

Access the full session

Session thumbnail
From guidelines to real-world practice: advancing low-density lipoprotein cholesterol control

The Event

Event poster

ESC Congress 2026

30 August 2026 10:21 CET
You may be interested in
thumbnail
Congress Presentation
Effectiveness and safety of bempedoic acid in routine clinical practice: 1-year follow-up snapshot of the MILOS German cohort
26 August 2023
thumbnail
Congress Presentation
Early use of triple single pill combination: make it a habit
30 August 2025
thumbnail
ESC TV Today
Episode 17: Coronary sinus reducer - Best strategies to reach LDL cholesterol goals
5 June 2025
thumbnail
Congress Presentation
Cardiac myosin inhibitors use in the real world: what you need to know
30 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources